4.3 Article

Women's attitudes about combined hormonal contraception (CHC)-induced menstrual bleeding changes-influence of personality traits in an Italian clinical sample

期刊

GYNECOLOGICAL ENDOCRINOLOGY
卷 -, 期 -, 页码 -

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/09513590.2023.2189971

关键词

Attitudes; bleeding pattern; tailored contraceptive regimen; personality; combined hormonal contraceptive

向作者/读者索取更多资源

This study investigated attitudes towards changing the frequency of menstrual bleeding using combined hormonal contraception (CHC) and explored personality characteristics. The study found that approximately 45% of women prefer to use CHC to change their bleeding frequency, with a flexible regimen being the most preferred choice. Positive reasons for this preference included avoiding dysmenorrhea and having more freedom in sexual and active life, while the main negative reason was the belief that menstrual rhythm is natural. Age and CHC usage significantly influenced women's willingness to change menstrual frequency using CHC, and personality traits such as openness and extroversion played a role in attitudes towards CHC-induced menstrual bleeding changes.
ObjectivesWe investigated the attitudes to change the frequency of menstrual bleeding by using combined hormonal contraception (CHC). Personality characteristics were also explored.MethodsWe conducted a cross-sectional study in two university hospitals in northern Italy. Current, past and never CHC users (n = 545; age 18-44 years) completed a self-administered semi-structured questionnaire and the Ten-Item Personality Inventory (TIPI).ResultsForty-five percent of responders (n = 301) would prefer to change their bleeding frequency by using CHC. A flexible regimen was the preferred choice (n = 80; 33%) followed by extended regimens to bleed every 3 months (n = 54; 22%) or to never bleed (n = 43; 18%). The main positive reasons were to avoid dysmenorrhea (43%) and have more freedom in sexual (36%) and active (35%) life, whereas the main reason for a negative attitude was 'menstrual rhythm is natural' (59%). Age had a significant influence on women's willingness to change menstrual frequency by using CHC [>39 years (57%), 30-39 years (31%) and <30 years (46%)] (chi(2): 9.1; p = 0.01). Never users significantly reported a more negative attitude (71%) in comparison with past (51%) and current users (49%) (chi(2): 18.7; p = 0.001). Personality traits played a role, with higher scores of openness (p = 0.005) and extraversion (p = 0.001) in women with a positive attitude.ConclusionsAlmost half of our study sample reported a preference for changing their menstrual pattern by using CHC. Flexibility was the preferred choice across age and use of CHC. Personality characteristics (openness and extroversion) might influence attitudes toward CHC-induced menstrual bleeding changes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study

Roberto De Icco, Laura Cucinella, Irene De Paoli, Silvia Martella, Grazia Sances, Vito Bitetto, Giorgio Sandrini, Giuseppe Nappi, Cristina Tassorelli, Rossella E. Nappi

JOURNAL OF HEADACHE AND PAIN (2016)

Review Geriatrics & Gerontology

Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)

Rossella E. Nappi, Laura Cucinella, Silvia Martella, Margherita Rossi, Lara Tiranini, Ellis Martini

MATURITAS (2016)

Review Obstetrics & Gynecology

Sexuality in premature ovarian insufficiency

R. E. Nappi, L. Cucinella, E. Martini, M. Rossi, L. Tiranini, S. Martella, D. Bosoni, C. Cassani

CLIMACTERIC (2019)

Review Endocrinology & Metabolism

Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women

Rossella E. Nappi, Ellis Martini, Laura Cucinella, Silvia Martella, Lara Tiranini, Alessandra Inzoli, Emanuela Brambilla, David Bosoni, Chiara Cassani, Barbara Gardella

FRONTIERS IN ENDOCRINOLOGY (2019)

Article Endocrinology & Metabolism

The role of hormone therapy in urogenital health after menopause

Rossella E. Nappi, Laura Cucinella, Ellis Martini, Chiara Cassani

Summary: Menopause presents challenges to urogenital health due to hormonal changes, leading to tissue degeneration. Genitourinary syndrome of menopause (GSM) is a clinical condition involving vaginal atrophy that negatively impacts quality of life.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Obstetrics & Gynecology

Sexuality, pelvic floor/vaginal health and contraception at menopause

Rossella E. Nappi, Laura Cucinella

Summary: This article summarizes key points for approaching sexual symptoms in midlife women, providing principles for diagnosing and managing hypoactive sexual desire disorder and genitourinary syndrome of menopause/vulvovaginal atrophy, as well as managing contraceptive needs.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2022)

Review Pharmacology & Pharmacy

Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?

Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani, Barbara Gardella

Summary: Female sexual dysfunctions (FSDs) are common and have a significant impact on quality of life and relationships. Current pharmacotherapies for FSDs are limited and safety is a concern. Recent research suggests that psychoactive agents and hormonal compounds are effective treatment options. However, there is a need for further research and a multimodal approach.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Article Genetics & Heredity

Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency

Fabio Sirchia, Elisa Giorgio, Laura Cucinella, Enza Maria Valente, Rossella E. Nappi

Summary: This case report reveals the presence of compound heterozygous variants in the PSMC3IP gene in a patient with secondary amenorrhea and her sister. It highlights the importance of including PSMC3IP in designed POI NGS panels or sequencing studies in patients with amenorrhea.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2022)

Article Urology & Nephrology

Medical Treatment of Female Sexual Dysfunction

Rossella E. Nappi, Lara Tiranini, Ellis Martini, David Bosoni, Alessandra Righi, Laura Cucinella

UROLOGIC CLINICS OF NORTH AMERICA (2022)

Article Geriatrics & Gerontology

Relationship between personality traits and sexual function in symptomatic postmenopausal women

Federica Barbagallo, Laura Cucinella, Lara Tiranini, Ellis Martini, David Bosoni, Pietro Molinaro, Federica Battista, Francesca Albani, Aldo E. Calogero, Rossella E. Nappi

Summary: This study found that personality traits are related to sexual function and mood in symptomatic postmenopausal women, with harm avoidance playing a mediating role. This suggests that in clinical practice, it may be useful to use psychometric tools to screen for mood disorders and assess personality traits in order to improve the diagnosis and treatment of sexual disorders in menopausal women.

MATURITAS (2022)

Article Endocrinology & Metabolism

Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype

F. Barbagallo, G. Pedrielli, D. Bosoni, L. Tiranini, L. Cucinella, A. E. Calogero, F. Facchinetti, R. E. Nappi

Summary: This study aimed to compare sexual function and distress in women with functional hypothalamic amenorrhea (FHA) and women with FHA and an underlying polycystic ovary syndrome (PCOS)-phenotype, considering their psychometric variables. The results showed that the psychometric profiles were similar in both groups, but women with typical FHA had more severe sexual impairment. Further studies should investigate the role of sex hormones in women's sexual functioning.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Review Clinical Neurology

Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?

Lara Tiranini, Laura Cucinella, Silvia Martella, David Bosoni, Ellis Martini, Rossella E. Nappi

Summary: Estrogen fluctuations affect pain threshold and have a significant role in menstrually related migraine (MRM). Exogenous estrogens can help manage MRM, but the use of combined hormonal contraception (CHC) should be carefully considered due to the increased risk of stroke. Different regimens and supplementation with estrogens during the hormone-free interval may have benefits for women with MRM.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)

Review Obstetrics & Gynecology

Menopause and female sexual dysfunctions

Laura Cucinella, Ellis Martini, Lara Tiranini, Federica Battista, Pietro Molinaro, Arianna Casiraghi, Selene Cominotti, Manuela Piccinino, Roberta Rossini, Rossella E. Nappi

Summary: Biological and psycho-relational factors contribute equally to the development of sexual symptoms and associated distress in menopausal women. Consultation during midlife is crucial for discussing sexual health, and healthcare providers should be proactive in addressing sexual concerns. An accurate sexual history is necessary to understand symptoms, assess their impact on quality of life, and identify risk factors. Hypoactive sexual desire disorder and genitourinary syndrome of menopause are common sexual dysfunctions in midlife. A multidimensional approach that considers patient characteristics, goals, and expectations is essential and should involve educational counseling and addressing modifiable risk factors. Specific treatments for FSDs should include non-pharmacological and pharmacological options to address both biological and psychosocial components.

MINERVA OBSTETRICS AND GYNECOLOGY (2022)

暂无数据